This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Young, S. Articles by Cohen, G. E. Search for Related Content PubMed PubMed Citation Articles by Young, S. Articles by Cohen, G. E.

Treatment of Verruca Plantaris with a Combination of Topical Fluorouracil and Salicylic Acid

^* Podiatry Division, Department of Orthopedics, Cabrini Medical Center, New York, NY.

Corresponding author: Simon Young, DPM, Podiatry Division, Department of Orthopedics, Cabrini Medical Center, 227 E 19th St, New York, NY 10003.

Abstract

A medical record review was conducted to determine the clinical outcome and average time to resolution of verruca plantaris in 20 patients treated with twice-daily applications of either 0.5% or 5.0% topical fluorouracil combined with topical 17% and 40% salicylic acid. Seven patients used 0.5% fluorouracil, and 13 used 5.0% fluorouracil. All of the lesions were sharply debrided at regular 1- or 2-week intervals. All 20 patients achieved full clinical resolution in a mean ± SD of 82.5 ± 56.6 days. Three patients (15%) had recurrent lesions, which subsequently resolved with repeated treatment. Two patients (10%) developed local dermatitis, which resolved with temporary discontinuation of the medication and the addition of a topical corticosteroid. It was observed that the twice-daily application of topical fluorouracil and salicylic acid is a safe and effective treatment for verruca plantaris. (J Am Podiatr Med Assoc 95(4): 366–369, 2005)

This article has been cited by other articles:

				M. M. Lipke An Armamentarium of Wart Treatments Clin. Med. Res., December 1, 2006; 4(4): 273 - 293. [Abstract] [Full Text] [PDF]